Structure

:: Overview
:: Mission Statement
:: Organisational Structure
:: European Experts

Committees

:: Management Board
:: CHMP
:: CVMP
:: COMP
:: HMPC
:: PDCO
:: CAT

Contact & Location

:: General Enquiries
:: Press Office
:: Pharmacovigilance
:: Product Defects
:: Certificates
:: Documentation
:: European Experts
:: IQM/Audits
:: Business Hours
:: Holidays 2010
:: How to Find Us

Meetings & Events

:: Meetings
:: Events

Recruitment

:: Recruitment Policy
:: Job Opportunities

Publishing Services

:: Online Mailing service
:: Important legal notice
:: Copyright Policy

See also

:: Calls for Tender
:: Fees Payable to the European Medicines Agency

 

Ring (44-7770) 92 44 29 for safety reporting Main contact details and Product Emergency Hotline

New visual identity of the European Medicines Agency

Product Information

:: Human Medicines
:: Veterinary Medicines
:: Safety Announcements
:: Withdrawals and Refusals
:: Summary of Opinions
:: Opinions for Orphan
Designation

:: Opinions for medicines
used outside the EU

Transparency policy
Medicines for children
Working with patients and consumers
Medicines for the Elderly
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
Addressing the needs of small and medium sized enterprises
Advanced Therapies
Medicines and Emerging Science
Preparing for the accession of new member states
New EU LegislationRoadmap 2015
EU Telematics

:: EudraGMP
:: EudraPharm Website
:: EudraCT Website
:: EudraCT Helpdesk
:: PIM website
:: eSubmission Website
:: EudraVigilance Website
:: EudraVigilance
Veterinary Website

:: EUTCT Website

Click here for CMDh Click here for CMDv

Information about pandemic influenza vaccines

Информация относно ваксини за пандемичен грипInformación sobre vacunas contra la pandemia gripal Informace o vakcínách proti pandemické chřipce Information om vacciner mod pandemisk influenza Informationen über Impfstoffe gegen pandemische Influenza Teave pandeemiliste gripivaktsiinide kohta Πληροφορίες για τα εμβόλια της πανδημικής γρίπης Informations sur les vaccins contre la grippe pandémiqueInformazioni sui vaccini per l’influenza pandemica Informācija par gripas pandēmijas vakcīnām Informacija apie vakcinas nuo pandeminio gripo Világméretű influenzajárvány elleni vakcinákra vonatkozó információk Informazzjoni dwar il-vaċċini għall-influwenza pandemika Informatie over vaccins tegen pandemische griep Informacje o szczepionkach przeciw grypie pandemicznej Informação sobre vacinas contra a pandemia da gripe Informaţii despre vaccinurile gripale pandemice Informácie o očkovacích látkach proti pandemickej chrípke Informacije o cepivih proti pandemični gripi Tietoa influenssapandemian aikana käytettävistä rokotteista Information om vacciner mot pandemisk influensa

 

Visit the Agency's pandemic influenza (H1N1) website

Latest pandemic pharmacovigilance report

 

New presentation of monthly figures on centralised procedures for human medicines

Published 08/02/2010

The European Medicines Agency has started publishing monthly figures related to the centralised procedure activities for human medicines in a new way.

These monthly figures will provide current information related to the volume and evaluation of marketing authorisation and post-authorisation applications for medicinal products for human use received by the European Medicines Agency. They are complementary to the CHMP monthly report and will be published on the Agency’s website within two weeks following the end of the CHMP meeting.

Monthly figures for January 2010

 

Agency launches public consultation on its 'Road Map to 2015' strategy paper

Published 26/01/2010

The European Medicines Agency has today published a draft paper setting out its vision for the strategic development of the Agency over the next five years.

Building on the progress of its previous five-year strategy, the new Road Map to 2015 charts the way forward for the Agency amid rapid developments in medical science and pharmaceutical research, as well as the continuing evolution of the European and international regulatory environments.

With this strategy paper to guide it, the Agency will seek to consolidate its achievements to date and further strengthen its role as a guardian of human and animal health in the European Union.

Read the draft 'Road Map to 2015'
Public feedback is welcome until 30 April 2010 by using the form available
A press release is also available

 

The European Medicines Agency marks its 15th anniversary with a short film

Published 26/01/2010

Inaugurated on 26 January 1995, the European Medicines Agency has now been working with its partners in the EU Member States to promote and protect human and animal health across the European Union for 15 years.

As part of its 15th anniversary celebrations, the Agency has commissioned a short film that provides a flavour of the ever-evolving environment in which it operates.

Watch the 5-minute film (30MB Download Quicktime here)

 

Latest Press Releases
27/01/10 EMA Committee on Advanced Therapies (CAT) celebrates its first birthday
27/01/10 EMA Public Statement on the withdrawal of the marketing authorisation in the European Union for Clopidogrel BMS (clopidogrel)
26/01/10 EMA European Medicines Agency launches consultation on its Road Map to 2015
22/01/10 CHMP CHMP Press Release from the January meeting
22/01/10 EMA European Medicines Agency updates on pandemic influenza
22/01/10 EMA European Medicines Agency gives first opinion on compassionate use
21/01/10 EMA European Medicines Agency recommends additional measures to better manage risk of progressive multifocal leukoencephalopathy (PML) with Tysabri
- See also: Questions and Answers
21/01/10 EMA European Medicines Agency recommends suspension of marketing authorisations for sibutramine
- See also Questions and Answers
   

See Press Office for archived press releases